Last reviewed · How we verify
Infusion of placebo during 48 hours — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Infusion of placebo during 48 hours (Infusion of placebo during 48 hours) — University Hospital, Rouen. A placebo infusion serves as an inert control intervention with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Infusion of placebo during 48 hours TARGET | Infusion of placebo during 48 hours | University Hospital, Rouen | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Infusion of placebo during 48 hours CI watch — RSS
- Infusion of placebo during 48 hours CI watch — Atom
- Infusion of placebo during 48 hours CI watch — JSON
- Infusion of placebo during 48 hours alone — RSS
Cite this brief
Drug Landscape (2026). Infusion of placebo during 48 hours — Competitive Intelligence Brief. https://druglandscape.com/ci/infusion-of-placebo-during-48-hours. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab